iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/14711465/
Further validation of the multidimensional fatigue symptom inventory-short form - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jan;27(1):14-23.
doi: 10.1016/j.jpainsymman.2003.06.003.

Further validation of the multidimensional fatigue symptom inventory-short form

Kevin D Stein  1 , Paul B Jacobsen, Chris M Blanchard, Christina Thors
Affiliations

Further validation of the multidimensional fatigue symptom inventory-short form

Kevin D Stein et al. J Pain Symptom Manage. 2004 Jan.

Abstract

A growing body of evidence is documenting the multidimensional nature of cancer-related fatigue. Although several multidimensional measures of fatigue have been developed, further validation of these scales is needed. To this end, the current study sought to evaluate the factorial and construct validity of the 30-item Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF). A heterogeneous sample of 304 cancer patients (mean age 55 years) completed the MFSI-SF, along with several other measures of psychosocial functioning including the MOS-SF-36 and Fatigue Symptom Inventory, following the fourth cycle of chemotherapy treatment. The results of a confirmatory factor analysis indicated the 5-factor model provided a good fit to the data as evidenced by commonly used goodness of fit indices (CFI 0.90 and IFI 0.90). Additional evidence for the validity of the MFSI-SF was provided via correlations with other relevant instruments (range -0.21 to 0.82). In sum, the current study provides support for the MFSI-SF as a valuable tool for the multidimensional assessment of cancer-related fatigue.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Confirmatory factor analysis of the MFSI-SF (Model 1).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist. 1999;4:1–10. - PubMed
    1. Cella DF, Peterman A, Passik S, et al. Progress toward guidelines for the management of fatigue. Oncology (Huntingt) 1998;12(11A):369–377. - PubMed
    1. Cella DF. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol. 1998;25(3Suppl 7):43–46. - PubMed
    1. Cimprich B. Development of an intervention to restore attention in cancer patients. Cancer Nurs. 1993;16(2):83–92. - PubMed
    1. Rhodes VA, Watson PM, Hanson BM. Patients’ descriptions of the influence of tiredness and weakness on self-care abilities. Cancer Nurs. 1988;11(3):186–194. - PubMed

Publication types